Skip to main content
SpringerLink
Log in

Propionyl-L-Carnitine

A Viewpoint by William R. Hiatt

  • Adis New Drug Profile
  • Guest Commentary
  • Published:
Drugs & Aging Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Criqui MH, Fronek A, Barrett-Connor E, et al. The prevalence of peripheral arterial disease in a defined population. Circulation 1985; 71: 510–5

    Article  PubMed  CAS  Google Scholar 

  2. Hiatt WR. Current and future drug therapies for claudication. Vasc Med 1997; 2: 257–62

    PubMed  CAS  Google Scholar 

  3. Brevetti G, Diehm C, Lambert D. European multicenter study of propionyl-L-carnitine in intermittent claudication. Circulation 1997; 96: 710–6

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Colorado Prevention Center, University of Colorado Health Sciences Center, Denver, Colorado, USA

    William R. Hiatt

Authors
  1. William R. Hiatt
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hiatt, W.R. Propionyl-L-Carnitine. Drugs & Aging 12, 249 (1998). https://doi.org/10.2165/00002512-199812030-00007

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00002512-199812030-00007

Keywords

Search

Navigation